phase readout
saveNCT05826366: Imfinzi/Imjudo NSCLC Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - CEI/SCEI
COMPLETEDupdated 1mo ago
community read0 votes
Sponsor: AstraZeneca. Phase: . Conditions: Carcinoma, Non-Small-Cell Lung
view source ↗
comments(0)
5-min edit window · permanent after that